These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Jaskowski TD, Litwin CM, Hill HR. Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338 [Abstract] [Full Text] [Related]
4. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP, Cobbold M, Wang Y, Goodall M, Bonney SL, Chamba A, Birtwistle J, Plant T, Afzal Z, Jefferis R, Drayson MT. J Immunol Methods; 2013 May 31; 391(1-2):1-13. PubMed ID: 23388695 [Abstract] [Full Text] [Related]
5. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio. Levinson SS. Ann Clin Lab Sci; 2010 May 31; 40(4):348-53. PubMed ID: 20947809 [Abstract] [Full Text] [Related]
6. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Clin Chem; 2002 Sep 31; 48(9):1437-44. PubMed ID: 12194920 [Abstract] [Full Text] [Related]
7. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population. Abadie JM, Bankson DD. Ann Clin Lab Sci; 2006 Sep 31; 36(2):157-62. PubMed ID: 16682511 [Abstract] [Full Text] [Related]
14. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation. Dogaru M, Lazăr V, Coriu D. Roum Arch Microbiol Immunol; 2011 Sep 31; 70(1):15-22. PubMed ID: 21717807 [Abstract] [Full Text] [Related]
15. [Progress in the management of multiple myeloma introduced by serum free light chain measurement]. Fuchida S, Shimazaki C. Nihon Rinsho; 2011 Dec 31; 69(12):2267-73. PubMed ID: 22242331 [Abstract] [Full Text] [Related]
16. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadogiannis A, Galanis Z, Kalpadakis C, Dimou M, Kyriakou E, Angelopoulou MK, Dimopoulou MN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Panayiotidis P, Pangalis GA. Br J Haematol; 2007 May 31; 137(3):240-3. PubMed ID: 17408464 [Abstract] [Full Text] [Related]
17. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma. Boyle EM, Fouquet G, Guidez S, Bonnet S, Demarquette H, Dulery R, Herbaux C, Noel MP, Manier S, Schraen S, Onraed B, Faucompré JL, Hennache B, Petillon MO, Mathiot C, Avet-Loiseau H, Facon T, Harding SJ, Moreau P, Leleu X. Cancer; 2014 Dec 15; 120(24):3952-7. PubMed ID: 25116271 [Abstract] [Full Text] [Related]
18. Assessment of serum free light chain levels in healthy adults immediately after marathon running. Campbell JP, Eijsvogels TM, Wang Y, Hopman MT, Jacobs JF. Clin Chem Lab Med; 2016 Mar 15; 54(3):459-65. PubMed ID: 26351935 [Abstract] [Full Text] [Related]
19. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio. Rindlisbacher B, Schild C, Egger F, Bacher VU, Pabst T, Leichtle A, Andres M, Sédille-Mostafaie N. J Appl Lab Med; 2020 Jan 01; 5(1):114-125. PubMed ID: 32445339 [Abstract] [Full Text] [Related]
20. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains. Xu Y, Sui W, Deng S, An G, Wang Y, Xie Z, Yao H, Zhu G, Zou D, Qi J, Hao M, Zhao Y, Wang J, Chen T, Qiu L. Leuk Lymphoma; 2013 Jan 01; 54(1):123-32. PubMed ID: 22712834 [Abstract] [Full Text] [Related] Page: [Next] [New Search]